NATIONAL INSTITUTES OF HEALTH
- Country
- πΊπΈUnited States
- Ownership
- Subsidiary, Private
- Established
- 1948-01-01
- Employees
- 1K
- Market Cap
- -
- Website
- http://www.nidcr.nih.gov
Vorinostat, Paclitaxel, and Carboplatin in Treating Patients With Advanced or Refractory Solid Tumors
- Conditions
- Unspecified Adult Solid Tumor, Protocol Specific
- Interventions
- Other: laboratory biomarker analysisOther: pharmacological study
- First Posted Date
- 2006-02-07
- Last Posted Date
- 2013-02-07
- Lead Sponsor
- National Cancer Institute (NCI)
- Target Recruit Count
- 30
- Registration Number
- NCT00287937
- Locations
- πΊπΈ
University of Pittsburgh, Pittsburgh, Pennsylvania, United States
Uric Acid in Essential Hypertension in Children
- First Posted Date
- 2006-02-07
- Last Posted Date
- 2017-09-14
- Target Recruit Count
- 30
- Registration Number
- NCT00288184
- Locations
- πΊπΈ
Texas Children's Hospital, Houston, Texas, United States
The Diabetes TeleCare Study
- Conditions
- Diabetes Mellitus, Type 2
- Interventions
- Behavioral: InterventionBehavioral: Usual Care
- First Posted Date
- 2006-02-07
- Last Posted Date
- 2018-03-02
- Target Recruit Count
- 165
- Registration Number
- NCT00288132
- Locations
- πΊπΈ
CareSouth Bennettsville, Bennettsville, South Carolina, United States
BAY 43-9006 (Sorafenib) to Treat Patients With Kaposi's Sarcoma
- First Posted Date
- 2006-02-06
- Last Posted Date
- 2019-12-12
- Lead Sponsor
- National Cancer Institute (NCI)
- Target Recruit Count
- 10
- Registration Number
- NCT00287495
- Locations
- πΊπΈ
National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States
Dietary Variety Versus Dietary Fat Effects in Energy Intake
- Conditions
- Healthy
- First Posted Date
- 2006-02-02
- Last Posted Date
- 2010-03-18
- Target Recruit Count
- 64
- Registration Number
- NCT00285571
- Locations
- πΊπΈ
Bastyr University, Kenmore, Washington, United States
Peer-enhanced Intervention to Support Teen Weight Loss
- Conditions
- Obesity
- Interventions
- Behavioral: CBT with supervised aerobic exerciseBehavioral: CBT with peer-enhanced activities
- First Posted Date
- 2006-02-02
- Last Posted Date
- 2017-10-06
- Target Recruit Count
- 118
- Registration Number
- NCT00285558
- Locations
- πΊπΈ
Bradley Hasbro Children's Research Center, Providence, Rhode Island, United States
HALT Progression of Polycystic Kidney Disease Study A
- Conditions
- Kidney, Polycystic
- Interventions
- Drug: PlaceboOther: Low Blood Pressure ControlOther: Standard Blood Pressure Control
- First Posted Date
- 2006-01-30
- Last Posted Date
- 2020-04-21
- Target Recruit Count
- 558
- Registration Number
- NCT00283686
- Locations
- πΊπΈ
University of Colorado Health Sciences Center, Aurora, Colorado, United States
πΊπΈTufts University-New England Medical Center, Boston, Massachusetts, United States
πΊπΈBeth Israel Deaconess Medical Center, Boston, Massachusetts, United States
Body Weight Regulation in Patients With Narcolepsy
- Conditions
- Narcolepsy
- First Posted Date
- 2006-01-30
- Last Posted Date
- 2017-10-06
- Target Recruit Count
- 30
- Registration Number
- NCT00283894
- Locations
- πΊπΈ
National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States
Combination Chemotherapy in Treating Young Patients With Advanced Solid Tumors
- Conditions
- Childhood Central Nervous System ChoriocarcinomaChildhood Central Nervous System Embryonal TumorChildhood Central Nervous System Germ Cell TumorChildhood Central Nervous System GerminomaChildhood Central Nervous System Mixed Germ Cell TumorChildhood Central Nervous System TeratomaChildhood Central Nervous System Yolk Sac TumorRecurrent Childhood Brain Stem GliomaRecurrent Childhood Central Nervous System Embryonal TumorUnspecified Childhood Solid Tumor, Protocol Specific
- Interventions
- Other: pharmacological studyProcedure: positron emission tomographyProcedure: computed tomography
- First Posted Date
- 2006-01-25
- Last Posted Date
- 2013-05-03
- Lead Sponsor
- National Cancer Institute (NCI)
- Target Recruit Count
- 42
- Registration Number
- NCT00281944
- Locations
- πΊπΈ
Memorial Sloan Kettering Cancer Center, New York, New York, United States
Sorafenib With Either Temsirolimus or Tipifarnib in Treating Patients With Stage IV Malignant Melanoma That Cannot Be Removed By Surgery
- Conditions
- Stage IV MelanomaRecurrent Melanoma
- Interventions
- First Posted Date
- 2006-01-25
- Last Posted Date
- 2014-05-20
- Lead Sponsor
- National Cancer Institute (NCI)
- Target Recruit Count
- 109
- Registration Number
- NCT00281957
- Locations
- πΊπΈ
Contra Costa Regional Medical Center, Martinez, California, United States
πΊπΈEl Camino Hospital, Mountain View, California, United States
πΊπΈGreat Falls Clinic, Great Falls, Montana, United States